Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Enzo Biochem

Article Abstract:

The price appreciation potential of Enzo Biochem, Inc. for the years 2010-2012 is discussed. The Farmingdale, New York-based company provides diagnostic testing services, manufactures DNA-based probes and reagents, and produces drugs against cancer and infectious diseases.

Author: Costanza, Andre J.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Evaluation, Stocks, Stock prices

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Enzo Biochem

Article Abstract:

A comparative analysis of the company sales and financial details of Enzo Biochem, Inc. from 1994 to 2003 are illustrated. Projections of the annual total returns, revenues and the assets position of the company for the period 2007-09 are made using value line estimates.

Author: Markey, Keith A.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, Company sales and earnings, Company earnings/profit

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Biological products industry, Securities, Company securities, Enzo Biochem Inc.
Similar abstracts:
  • Abstracts: Park Electrochem
  • Abstracts: BCE Inc. BT Group
  • Abstracts: Gencorp. Ariba Inc. Fondry Networks Inc.
  • Abstracts: Celgene Corp. Techne Corp. Biotechnology Industry
  • Abstracts: AMGEN. Luxottica
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.